Schaeffer's Top Stock Picks for '25

Revance Therapeutics Stock Nosedives on FDA News

RVNC's options pits are bursting with activity this morning

Deputy Editor
Oct 18, 2021 at 11:19 AM
facebook X logo linkedin


Revance Therapeutics Inc (NASDAQ:RVNC) is plummeting today, last seen down 41.9% to trade at $13.21. This plunge came after news that the U.S. Food and Drug Administration (FDA) declined to approve Revance's facial line treatment, which was seen as a possible Botox competitor, due to issues with the company's manufacturing facility.

The stock's typically quiet options pits are bustling with activity this morning. Options volume is running at 12 times what is typically seen at this point, with 2,813 calls and 922 puts across the tape so far. The November 15 call is most popular, followed by the 12.50 put in the same monthly series, with new positions currently being opened at both.

Due to today's volatile swing, RVNC has landed on the Short Sale Restricted (SSR) list. Short interest has been on the rise, and makes up 5.3% of the stock's available float, or nearly two weeks' worth of pent-up buying power. 

Analysts are already chiming in with bear notes. The security has received four price-target cuts, including one from Wainwright to $18 from $26. The brokerage bunch was optimistic toward Revance Therapeutics stock, with all nine analysts in coverage calling it a "buy" or better. Plus, the 12-month consensus price target of $33.78 is a whopping 154.9% premium to current levels, indicating RVNC could see additional price-target cuts and/or downgrades.

On the charts, Revance Therapeutics stock earlier hit a fresh annual low of $13.01. The shares have also breached a recent floor at the $22 level, and are now off 53.5% year-to-date.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?